Chambers Review
Provided by Chambers
Life Sciences (International Firms) - China
What the Team is Known For
Paul Hasting is growing its presence in the life sciences and healthcare space with a noteworthy track record of assisting pharmaceutical companies with internal and governmental investigations, ABAC compliance and risk assessments. The firm's transactional capability is sought after by pharmaceutical companies and investors to handle acquisitions and investments. It also swiftly deals with disputes over licensing agreements and shareholder agreements. Additionally, the team is also adept at data privacy and cybersecurity compliance.
Strengths
It has a strong capability to help clients translate unique issues under Chinese circumstances into understandable language for alignment with headquarters in the US.
Paul Hasting has professional staff with strong technical knowledge and business acumen. They are responsive, knowledgeable and thorough.
Work Highlights
Paul Hastings represented Chindex Medical in its and other investors’ subscription of new shares in Telefield Medical Imaging. The client became Telefield Medical Imaging’s largest preferred shareholder out of all investors after the issuance and subscription of new shares.
Notable practitioners
Phoebe Yan leads Paul Hastings' life sciences practice in Asia. She has notable expertise advising clients on investigations and compliance matters. Working from the firm's base in Shanghai, she attracts regular instructions from foreign and Chinese entities in the pharmaceutical and biotechnology sectors.
Phoebe is great. If you are a US publicly traded multinational, she is the lawyer to help you out.
Phoebe always provides excellent client service.